We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
ACT-HIB haemophilus type B conjugate vaccine (conjugated to tetanus protein) powder for injection vial and needle free diluent syringe (130161)
ARTG ID 130161
ARTG Name
ACT-HIB haemophilus type B conjugate vaccine (conjugated to tetanus protein) powder for injection vial and needle free diluent syringe
Product name
ACT-HIB Haemophilus type b conjugate vaccine powder for injection with needle free diluent syringe
ARTG Date
Registration Type
Medicine
Therapeutic good type
Medicines
Sponsor
Ingredients
Haemophilus type B polysaccharide
Tetanus protein
Licence category
RE
Licence status
A
Summary
Product Information
Consumer Medicine Information